Transfection technologies market to value $1.5 billion by 2026
Growth in the global transfection technologies market will be driven by emerging methods and the increasing prevalence of chronic diseases over the next five years.
List view / Grid view
Growth in the global transfection technologies market will be driven by emerging methods and the increasing prevalence of chronic diseases over the next five years.
22 October 2015 | By Laura Juckem, PhD, R&D Group Leader at Mirus Bio
Laura Juckem, PhD, R&D Group Leader at Mirus Bio, discusses the company’s systems for optimising suspension Chinese hamster ovary (CHO) cells...
During early stage drug development, quickly obtaining relevant candidate proteins through transient transfection can accelerate drug discovery.
In this Stem Cells In-Depth Focus: Stem cell therapies: Assuring safety; Role of pluripotent stem cells in neurotoxicology testing: Impacts and applied innovations...